Lys Therapeutics
Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke
>€25MSeed
Role not disclosedActivity from announced rounds
Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke
Develops silicon qubits for dense integration and compatibility with industrial fabrication standards
Pitching Bpifrance? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room